Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Phase I Trial
100%
Epitope Vaccine
100%
B-cell Epitope
100%
Solid Tumors
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Combination Vaccine
40%
Peptide Vaccine
40%
Human Immune System
40%
Specific Aims
40%
Immune System
40%
Gastric Cancer
20%
HER Signaling
20%
Native-like
20%
Tumor Antigen
20%
Synthetic Peptides
20%
Clinical Trials
20%
Trastuzumab/Herceptin
20%
Immunotherapeutic Interventions
20%
Immunological Monitoring
20%
Clinical Toxicity
20%
Clinical Research
20%
Discovery-based
20%
Physician-scientist
20%
Metastatic Cancer
20%
Humoral Immune Response
20%
Passive Immunity
20%
Anti-peptide Antibody
20%
Public Health Impact
20%
Anti-tumor Response
20%
Antitumor Activity
20%
Human Epidermal Growth Factor Receptor
20%
Native Structure
20%
Endogenous Antibodies
20%
In Cancer
20%
Safety Toxicity
20%
Highly Effective
20%
In Vitro Activity
20%
Endometrial Cancer
20%
HER1
20%
T Cells
20%
Breast Cancer
20%
HER3
20%
Signal Inhibition
20%
Human Trials
20%
Epitope Peptide
20%
No Toxicity
20%
Lung Cancer
20%
Active Immunization
20%
Tumor-specific Immune Response
20%
Scientific Advances
20%
HER4
20%
HER Receptors
20%
Targeted Cancer Therapy
20%
Cellular Immune Response
20%
Mechanism of Action
20%
Cancer Patients
20%
Uterine Cancer
20%
Patient Care
20%
Immunization
20%
Esophageal Cancer
20%
Clinical Science
20%
Clinical Impact
20%
Basic Scientist
20%
High Efficacy
20%
Vaccination
20%
Immune Memory
20%
Lines of Defense
20%
Tumor Cells
20%
Tumor Growth
20%
Ovarian Cancer
20%
Tumor Metastasis
20%
Early Phase Clinical Trials
20%
Pharmacology, Toxicology and Pharmaceutical Science
Phase I Trials
100%
Epitope
100%
Solid Malignant Neoplasm
100%
Malignant Neoplasm
100%
Neoplasm
42%
Trastuzumab
28%
Clinical Trial
28%
Immunotherapy
28%
Clinical Research
28%
Peptide Vaccine
28%
Epidermal Growth Factor Receptor
28%
Combination Vaccine
28%
Peptide
14%
Receptor
14%
Abdominal Cancer
14%
Gamma Urogastrone
14%
Breast Cancer
14%
Clinical Study
14%
Tumor Antigen
14%
Lung Cancer
14%
Uterus Cancer
14%
Vaccination
14%
Tumor Growth
14%
Preclinical Study
14%
Synthetic Peptide
14%
Immunology and Microbiology
Epitope
100%
Immune System
100%
B Cell
100%
Peptides
50%
Trastuzumab
50%
In Vitro
50%
Peptide Vaccine
50%
Immune Response
25%
Humoral Immunity
25%
Tumor Cell
25%
Adoptive Immunity
25%
Immunotherapy
25%
T Cell
25%
Antineoplastic Activity
25%
Gamma Urogastrone
25%
Preclinical Study
25%
Active Immunotherapy
25%
Lung
25%
Tumor Antigen
25%
Immunological Memory
25%